There is not much room for adjustment here.JeopardygameOh, 3100 at the most. In the direction, biomedicine (synthetic biology and CRO innovative drugs) is the strongest main line at present, and it will be a high certainty buying point if it resonates with the index tomorrow. The superimposed performance line, especially the pre-increase in the quarterly report, is still an addition. Just read the news, tomorrow artificial intelligence technology stocks are estimated to be bad luck, originally do not play, let it go. Low-altitude economy, do not pay too much attention. Technology stocks can not, tomorrow's index is adjusted or can be strong horizontal, the key depends on the direction of new energy batteries.
Recently, as the focus is on biomedical work, it is not difficult to keep big meat in succession. Don't be sad if you lose money today. The market moves very fast. It is normal for you to lose money in other directions of miscellaneous hair. Finally, talk about something a little more serious.
Key words Biopharmaceuticals, CRO innovative drugs, Quarterly bullish, bullish (bullish) Biomedicine is the strongest main line at present, the space for index adjustment is limited, pre-increase in performance is an additional item, the performance of technology stocks is poor, the key depends on the direction of new energy batteries. fiveJeopardygame.8 young model of the clubhouse, continueJeopardygame... Risk Tip of Hexun self-selected WriterJeopardygameThe above content is only the views of the author or guest, does not represent any position of Hexun, and does not constitute any investment suggestions related to Hexun. Before making any investment decision, investors should consider the risk factors related to investment products according to their own circumstances and consult professional investment advisers if necessary. Hexun tries its best but cannot confirm the authenticity, accuracy and originality of the above content, and Hexun does not make any guarantee or commitment.